AdvaMed Encourages Risk -Based FDA Approach to Generative AI Medical Devices
WASHINGTON—AdvaMed, the Medtech Association, encouraged the U.S. Food and Drug Administration (FDA) to build on its existing regulatory framework ...
Read the original at AdvaMed ↗
- Topics
- HealthcareChatbots & LLMsRegulation & PolicyGovernance & Risk Management
- Mentions
- FDAUnited States
- Tracked via
- “AI Risks”